The House Energy and Commerce Committee today approved six AHA-supported bills to address the opioid crisis:

  • H.R. 5176 would provide grants for hospitals to develop protocols to connect opioid overdose patients with substance use disorder treatment.
  • H.R. 5197, as amended, would provide grants to test alternative pain management protocols to limit opioid use and prescribing in hospital emergency departments.
  • H.R. 5582 would direct the Secretary of Health and Human Services to study and report to Congress on the adequacy of access to abuse-deterrent opioid formulations for Medicare Advantage and prescription drug plan beneficiaries with chronic pain.
  • H.R. 5685 would direct the Centers for Medicare & Medicaid Services to include educational resources on opioid use, pain management and alternative pain management treatments in the “Medicare and You” handbook.
  • H.R. 5686 would require Medicare prescription drug plans to provide certain enrollees with information on the adverse effects of opioid overuse and coverage of alternative pain medications or devices.
  • H.R. 4841 would standardize electronic prior authorization for prescription drugs under Medicare Part D.

“We applaud the leadership of Chairman Walden, Ranking Member Pallone and the Energy and Commerce Committee in advancing several measures that will help hospitals continue to fight the epidemic,” said AHA Executive Vice President Tom Nickels. The committee will mark up additional opioid-related bills next week. The Senate Health, Education, Labor and Pensions Committee last month approved bipartisan legislation that would reauthorize funding to states to address opioid abuse and provide support to improve the interoperability of state prescription drug monitoring programs. Other committees, including House Ways and Means and Senate Finance, also are considering opioid-related legislation.

Related News Articles

Nearly 70 organizations, including the AHA, today urged congressional leaders to advance the House-passed Pandemic and All-Hazards Preparedness…
The Department of Health and Human Services this week awarded $487 million in fiscal year 2019 grants to help states and territories increase access to…
The three medications approved by the Food and Drug Administration to treat opioid use disorder — methadone, buprenorphine and extended-release naltrexone —…
In a study of Blue Cross and Blue Shield enrollees reported last week in the New England Journal of Medicine, initial opioid prescriptions declined 54 percent…
As our country works to expand health coverage and improve access to care, “Medicare for All” is getting a lot of attention. There are many different flavors…
Reps. Terri Sewell, D-Ala., and John Katko, R-N.Y., today introduced the Resident Physician Shortage Reduction Act of 2019 (H.R. 1763) that would add up to 15,…